Arno Therapeutics, Inc. HomeAbout UsPipelineInvestor RelationsContact Us
Creating the next generation of cancer treatments
Investor & Media
Press ReleasesIn the NewsPublicationsEvents & PresentationsStock Information
SEC FilingsAnnual ReportsGovernanceTransfer Agent

PRESS RELEASES



September 8, 2014

Arno Therapeutics to Present at Upcoming Investor Conferences

FLEMINGTON, NJ - September 8, 2014 - Arno Therapeutics, Inc. (OTCQB: ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced that Dr. Alex Zukiwski, Chief Executive Officer and Mr. Lawrence Kenyon, Chief Financial Officer, are scheduled to present at the 16th Annual Rodman & Renshaw Global Investment conference being held September 8-10, 2014 in New York and the Aegis Capital 2014 Healthcare & Technology Conference being held September 10-13, 2014 in Las Vegas.

Details of the presentations are as follows:
Conference:Rodman & Renshaw Global Investment Conference
Date:Tuesday, September 9, 2014
Time:3:45 p.m. EDT
Conference:Aegis Capital 2014 Healthcare & Technology Conference
Date:Thursday, September 11, 2014
Time:11:25 a.m. PDT
Investors attending the conferences who would like to schedule a 1-on-1 meeting with Arno management may do so by contacting their Rodman & Renshaw or Aegis Capital representatives, or Lee Roth of The Ruth Group at lroth@theruthgroup.com.

About Arno Therapeutics

Arno Therapeutics is a clinical stage biopharmaceutical company developing innovative products for the treatment of cancer. Arno has exclusive worldwide rights to develop and market three innovative anti-cancer product candidates. These compounds are in clinical or preclinical development as product candidates to treat hematologic malignancies and solid tumors. For more information about the company, please visit www.arnothera.com.




The Ruth Group
Lee Roth (investors)
lroth@theruthgroup.com
(646) 536-7012

Kirsten Thomas (media)
kthomas@theruthgroup.com
(646) 536-7014

Arno Therapeutics
Lawrence Kenyon
lk@arnothera.com
(862) 703-7171



Arno Therapeutics, Inc.
200 Route 31 North
Suite 104
Flemington, NJ 08822

(862) 703-7170 Main
(908) 237-0071 Fax

Email